Bone Biopsy Systems Market Size is Projected to Reach US$ 507.1 Million by 2035 With a CAGR of 6.3% | Fact.MR

The size of the bone biopsy systems market was USD 276.2 million in 2025. According to the Fact.MR report, the market for bone biopsy systems is set to increase at a 6.3% CAGR and will reach USD 507.1 million in 2035. The demand is being driven by the increase in the incidence rate of bone disease conditions such as metastatic bone cancer, osteomyelitis, lymphoma, and metabolic diseases such as osteoporosis in the world.

Early diagnosis and tissue differentiation have become significant in infectious disease and cancer diagnosis, and precision biopsy instruments have continued to have steady demand. Physicians are increasingly using bone biopsy systems enabling high diagnostic yield with minimal invasiveness.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=3884

Country-wise Analysis

The USA bone biopsy systems market is expected to grow at 7.2% CAGR during the study. Strong growth will be experienced with the high prevalence of bone disease, increasing geriatric population, and advancements in diagnostic imaging technology and minimally invasive techniques. Growing awareness regarding the importance of early detection of bone deformities such as osteoporosis and bone cancer has been a crucial factor in boosting the demand for biopsy systems.

The UK bone biopsy systems market will be expanding at 6.3% CAGR during the study period. This expansion is supported by the increasing rate of musculoskeletal disorders and growing incidence of cancer, which requires the utilization of diagnostic biopsies.

The South Korean bone biopsy systems market will advance at 6.5% CAGR between the forecast years. An aging population and growing incidence of bone cancers and metabolic bone diseases are fuelling robust demand for efficient diagnostic products.

The Australia-New Zealand bone biopsy systems market will be growing at 6.0% CAGR during the forecast period. The region's highly developed healthcare system and rising incidence of oncological and musculoskeletal diseases are driving the demand for precise diagnostic methods such as bone biopsies.

Segment-wise Analysis

By Use Case

Bone marrow biopsy will dominate the bone biopsy systems market by 2025 with a 60% share, while bone lesions biopsy takes up the other 40% of the share.

By Diagnostic Application

The bone disorder diagnosis segment will be the key driver of the bone biopsy systems market in 2025 and is anticipated to hold 28% of the overall revenue share. This segment will be trailed by Bone Cancer Diagnosis, which is anticipated to hold 25% of the remaining share.

By way of illustration

Stryker provides its OnControl® Bone Biopsy System, which patients would prefer to utilize for oncology, as it simplifies the retrieval of samples very easily while enhancing comfort. Furthermore, Argon Medical Devices produces a vast range of biopsy needles to diagnose bone cancer.

Competitive Outlook

The Bone Biopsy Systems Market is highly competitive with top medical device manufacturers and specialized diagnostic companies. Post-2024, players such as Becton, Dickinson and Company (BD), Stryker Corporation, Merit Medical Systems, Argon Medical Devices, and Cardinal Health became market leaders in product and geographic territory expansion.

BD solidified its leadership with the launch of the TruCore® Bone Marrow Biopsy System, which combines with the TruGuideTM Bone Access System that is supposed to increase procedural efficacy and safety. Stryker launched the OsteoScoop2 Bone Biopsy Needle, which offers enhanced visibility and stability to procedures. Merit Medical Systems launched the QuikCoreTM Bone Biopsy System to supplement its ACCESSTM Bone Biopsy System and strengthened its presence in the Asia-Pacific region through acquisitions.

Argon Medical Devices collaborated with Terumo India to market bone biopsy needles in India's rapidly growing market. Cardinal Health continues to lead the way in minimally invasive biopsy products that include bone marrow biopsy and aspiration needles.

Browse Full Report: https://www.factmr.com/report/3884/bone-biopsy-systems-market

Key Players

Becton, Dickinson and Company (BD)
Stryker Corporation
Merit Medical Systems
Argon Medical Devices
Cardinal Health
Cook Group Incorporated
Kimal PLC
Remington Medical
Mermaid Medical A/S
Laurane Medical

Segmentation

By Use Case:
Bone Marrow Biopsy
Bone Lesion Biopsy

By Diagnostic Application:
Bone Disorder Diagnosis
Bone Cancer Diagnosis
Bone Infection Detection
Chronic Kidney Disease Diagnosis
Others (Differentiating between Benign and Malignant Tumors)

By End-User:
Hospitals
Orthopedic Clinics
ASCs (Ambulatory Surgery Centers)

By Region:
North America
Latin America
Europe
East Asia
South Asia & ASEAN
Oceania
Middle East & Africa

Check out More Related Studies Published by Fact.MR:

Endoscopy Cameras Market
https://www.factmr.com/report/endoscopy-cameras-market
Air Ambulance Services Market
https://www.factmr.com/report/air-ambulance-services-market
Patient Positioning System Market
https://www.factmr.com/report/52/patient-positioning-market
Dental Consumables Market
https://www.factmr.com/report/4420/dental-consumables-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.